Latest News and Press Releases
Want to stay updated on the latest news?
-
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease symptoms in this underserved patient populationADAPT SERON,...
-
London, UK, April 17, 2026 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”), today disclosed that on April 15, 2026, it received formal notification from Nasdaq...
-
RANCHO CORDOVA, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking...
-
NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. (NASDAQ: NKLR) (“Terra” or the “Company”), developer of the SOLO™ Micro-Modular Reactor, today disclosed receipt of a Nasdaq...
-
FORT WORTH, Texas, April 17, 2026 (GLOBE NEWSWIRE) -- American Airlines Group Inc. (NASDAQ: AAL) today issued the following statement: We appreciate the leadership and strong support of President...
-
FLOWER MOUND, Texas, April 17, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make...
-
ONTARIO, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- CVB Financial Corp. (the “Company”) announced today that the planned mergers between CVB Financial Corp. (Nasdaq: “CVBF”) and Heritage Commerce...
-
Tel Aviv, Israel, April 17, 2026 (GLOBE NEWSWIRE) -- Arbe Robotics Ltd. (NASDAQ: ARBE) (TASE: ARBE), a global leader in perception radar solutions, today announced that on April 13, 2026, the...
-
SAN CARLOS, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and...
-
IRVING, Texas, April 17, 2026 (GLOBE NEWSWIRE) -- Sow Good Inc. (NASDAQ: SOWG), a freeze-dried food and candy manufacturer, announced today that its Board of Directors has approved a 15-to-1 reverse...